| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
ICLR
Icon
|
Feb 17, 2026 | HOLD |
Strong Buy
+13.8% avg upside
26 analysts
|
$100.00
39.29% Downside
|
+88.6% | · |
|
CERT
Certara
|
Nov 21, 2025 | BUY |
Buy
+61.7% avg upside
22 analysts
|
$10.00
23.51% Upside
|
-5.9% | · |
|
WST
West Pharmaceutical Services
|
Sep 15, 2025 | BUY |
Strong Buy
+4.4% avg upside
18 analysts
|
$311.00
10.91% Downside
|
+36.9% | · |
|
MEDP
Medpace Holdings
|
Sep 03, 2025 | HOLD |
Buy
-19.9% avg upside
17 analysts
|
$474.00
21.40% Downside
|
+24.5% | · |
|
CRL
Charles River Labs
|
May 23, 2025 | BUY |
Strong Buy
-16.3% avg upside
35 analysts
|
$182.00
34.48% Downside
|
+17.2% | · |
|
DGX
Quest Diagnostics
|
Apr 02, 2025 | BUY |
Buy
-22.7% avg upside
34 analysts
|
$195.00
17.79% Downside
|
+20.1% | · |
|
LH
Labcorp Holdings
|
Apr 02, 2025 | BUY |
Strong Buy
-15.8% avg upside
37 analysts
|
$276.00
14.32% Downside
|
+17.0% | · |
|
CH:LONN
Lonza Group Ltd
|
Nov 27, 2024 | BUY |
Strong Buy
+13.0% avg upside
21 analysts
|
$650.00
12.90% Upside
|
+6.4% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.